Veterinary Medicines

Vepured (--) - Suspension for injection

Authorised
  • Escherichia coli, recombinant Shiga toxin 2e
Download as PDF

Product identification

Medicine name:
Vepured (--) - Suspension for injection
Active substance:
  • Escherichia coli, recombinant Shiga toxin 2e
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Escherichia coli, recombinant Shiga toxin 2e
    Presentation_strength:≥ 1.50 Reference:Ph.Eur. current edition, monograph 00062 Index:0
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Bottle (PET), Package_size:1 bottle, Content:10 ml (10 doses)
  • Packaging:Bottle (PET), Package_size:1 bottle, Content:100 ml (100 doses)
  • Packaging:Bottle (PET), Package_size:1 bottle, Content:50 ml (50 doses)
  • Packaging:Bottle (PET), Package_size:10 bottles, Content:10 ml (10 doses)
  • Packaging:Bottle (PET), Package_size:1 bottle, Content:250 ml (250 doses)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra, S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 7/03/2025
Download
Bulgarian (PDF)
Published on: 7/03/2025
Download
Croatian (PDF)
Published on: 7/03/2025
Download
Czech (PDF)
Published on: 7/03/2025
Download
Danish (PDF)
Published on: 7/03/2025
Download
Dutch (PDF)
Published on: 7/03/2025
Download
Estonian (PDF)
Published on: 7/03/2025
Download
Finnish (PDF)
Published on: 7/03/2025
Download
French (PDF)
Published on: 7/03/2025
Download
German (PDF)
Published on: 7/03/2025
Download
Greek (PDF)
Published on: 7/03/2025
Download
Hungarian (PDF)
Published on: 7/03/2025
Download
Icelandic (PDF)
Published on: 7/03/2025
Download
Italian (PDF)
Published on: 7/03/2025
Download
Latvian (PDF)
Published on: 7/03/2025
Download
Lithuanian (PDF)
Published on: 7/03/2025
Download
Maltese (PDF)
Published on: 7/03/2025
Download
Norwegian (PDF)
Published on: 7/03/2025
Download
Polish (PDF)
Published on: 7/03/2025
Download
Portuguese (PDF)
Published on: 7/03/2025
Download
Romanian (PDF)
Published on: 7/03/2025
Download
Slovak (PDF)
Published on: 7/03/2025
Download
Slovenian (PDF)
Published on: 7/03/2025
Download
Spanish (PDF)
Published on: 7/03/2025
Download
Swedish (PDF)
Published on: 7/03/2025
Download

ema-puar-vepured-v-4364-par-en.pdf

English (PDF)
Published on: 17/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."